Books in Drug adverse reactions and interactions

1-10 of 31 results in All results

Essentials of Translational Pediatric Drug Development

• 1st Edition
• July 22, 2024
• Elke Gasthuys + 3 more
• English
• Paperback 978-0-323-88459-4

  9 7 8 - 0 - 3 2 3 - 8 8 4 5 9 - 4
• eBook 978-0-323-90429-2

  9 7 8 - 0 - 3 2 3 - 9 0 4 2 9 - 2

Essentials of Translational Pediatric Drug Development: From Past Needs to Future Opportunities provides integrated and up-to-date insights relevant for both translational researchers and clinicians active in the field of pediatric drug development. The book covers all key aspects from different stakeholder perspectives, providing a literature overview and careful reflection on state-of-the-art approaches. It will be an ideal guide for researchers in the field who are designing and performing high quality, innovative pediatric-adapted drug development by helping them define needs/challenges and possible solutions that advance and harmonize pediatric drug development.Despite the broad consensus that children merit the same quality of drug treatment as any other age group, children remain frequently neglected during drug research and development. Even with the adoption of multiple legislations addressing this problem, the lack of efficacy and safety data of marketed as well as newly developed drugs still remain in the pediatric population.

Deprescribing and Polypharmacy in an Aging Population

• 1st Edition
• August 22, 2023
• Ali Elbeddini
• English
• Paperback 978-0-323-99138-4

  9 7 8 - 0 - 3 2 3 - 9 9 1 3 8 - 4
• eBook 978-0-323-99381-4

  9 7 8 - 0 - 3 2 3 - 9 9 3 8 1 - 4

Deprescribing and Polypharmacy in an Aging Population supports healthcare professionals across global healthcare institutions in reducing polypharmacy-related drug replated problems (DRPs) by working with patients, families, interprofessional healthcare professionals, and educational institutions to develop, implement, test, improve upon, and educate on strategies for deprescribing and optimizing patient safety. Polypharmacy, the use of multiple medications at the same time by one person, is very common in various patient populations, including those who lack primary physicians, patients with mental health conditions, patients with multiple chronic conditions, and in the aging population.

Atkinson's Principles of Clinical Pharmacology

• 4th Edition
• October 16, 2021
• Shiew-Mei Huang + 3 more
• English
• Hardback 978-0-12-819869-8

  9 7 8 - 0 - 1 2 - 8 1 9 8 6 9 - 8
• eBook 978-0-12-819884-1

  9 7 8 - 0 - 1 2 - 8 1 9 8 8 4 - 1

**Selected for Doody’s Core Titles® 2024 in Pharmacology**Atkinson’s Principles of Clinical Pharmacology, Fourth Edition is the essential reference on the pharmacologic principles underlying the individualization of patient therapy and contemporary drug development. This well-regarded survey continues to focus on the basics of clinical pharmacology for the development, evaluation and clinical use of pharmaceutical products while also addressing the most recent advances in the field. Written by leading experts in academia, industry, clinical and regulatory settings, the fourth edition has been thoroughly updated to provide readers with an ideal reference on the wide range of important topics impacting clinical pharmacology.

Drug Delivery Devices and Therapeutic Systems

• 1st Edition
• November 7, 2020
• Eric Chappel
• English
• Paperback 978-0-12-819838-4

  9 7 8 - 0 - 1 2 - 8 1 9 8 3 8 - 4
• eBook 978-0-12-819839-1

  9 7 8 - 0 - 1 2 - 8 1 9 8 3 9 - 1

Drug Delivery Devices and Therapeutic Systems examines the current technology and innovations moving drug delivery systems (DDS) forward. The book provides an overview on the therapeutic use of drug delivery devices, including design, applications, and a description of the design of each device. While other books focus on the therapy, the primary emphasis in this book is on current technologies for DDS applications, including microfluidics, nanotechnology, biodegradable hydrogel and microneedles, with a special emphasis on wearable DDS. As part of the Developments in Biomedical Engineering and Bioelectronics series, this book is written by experts in the field and informed with information directly from manufacturers. Pharmaceutical scientists, medical researchers, biomedical engineers and clinical professionals will find this an essential reference.

Medicinal Plants in Asia and Pacific for Parasitic Infections

• 1st Edition
• October 20, 2020
• Christophe Wiart
• English
• Paperback 978-0-12-816811-0

  9 7 8 - 0 - 1 2 - 8 1 6 8 1 1 - 0
• eBook 978-0-12-816812-7

  9 7 8 - 0 - 1 2 - 8 1 6 8 1 2 - 7

Medicinal Plants in Asia and Pacific for Parasitic Infections: Botany, Ethnopharmacology, Molecular Basis, and Future Prospect offers an in-depth view into antiprotozoal pharmacology of natural products from medicinal plants in Asia with an emphasis on their molecular basis, cellular pathways, and cellular targets. This book provides scientific names, botanical classifications, botanical description, medicinal uses, chemical constituents and antiprotozoal activity of more than 100 Asian medicinal plants, with high quality original botanical plates, chemical structures, and pharmacological diagrams and lists hundreds of carefully selected references. It also examines the pharmacological and medicinal applications of Asian medicinal plants especially in drug development for protozoan prevention and treatment. Medicinal Plants in Asia and Pacific for Parasitic Infections is a research tool and resource for the discovery of leads for the treatment of protozoal diseases based on interrelated botanical, biochemical, ethnopharmacological, phylogenetic, pharmacological, and chemical information.

Post-Authorization Safety Studies of Medicinal Products

• 1st Edition
• June 19, 2018
• Ayad K. Ali + 1 more
• English
• Hardback 978-0-12-809217-0

  9 7 8 - 0 - 1 2 - 8 0 9 2 1 7 - 0
• eBook 978-0-12-809208-8

  9 7 8 - 0 - 1 2 - 8 0 9 2 0 8 - 8

Post-Authorization Safety Studies of Medicinal Products: The PASS Book bridges the gap in the literature by providing a complete look at post-authorization safety studies and important pharmacoepidemiology and pharmacovigilance aspects. It covers various types and limitations of active surveillance programs, including the use of large databases and disparate data sources for rapid signal detection, as well as novel and advanced design and analysis approaches for causal interference from observational data. This book serves as an important reference for pharmacovigilance scientists and pharmacoepidemiologists who are searching for the appropriate study design to answer safety research questions. Readers will be able to effectively and efficiently design and interpret findings from post-authorization safety studies with the goal of improving the benefit-risk balance of a drug in order to optimize patient safety.

Medicinal Plants for Holistic Health and Well-Being

• 1st Edition
• September 27, 2017
• Namrita Lall
• English
• Paperback 978-0-12-812475-8

  9 7 8 - 0 - 1 2 - 8 1 2 4 7 5 - 8
• eBook 978-0-12-812476-5

  9 7 8 - 0 - 1 2 - 8 1 2 4 7 6 - 5

Medicinal Plants for Holistic Health and Well-Being discusses, in depth, the use of South African plants to treat a variety of ailments, including tuberculosis, cancer, periodontal diseases, acne, postmacular hypomelanosis, and more. Plants were selected on the basis of their traditional use, and the book details the scientific evidence that supports their pharmacological and therapeutic potential to safely and effectively treat each disease. Thus, this book is a valuable resource for all researchers, students and professors involved in advancing global medicinal plant research. Many plants found in South Africa are also found in other parts of the world. Each chapter highlights plants from other worldwide locations so that scientists can study which plants belong to the same family, and how similar qualities can be used to treat a specific disease.

Adverse Events and Oncotargeted Kinase Inhibitors

• 1st Edition
• May 8, 2017
• Giuseppe Tridente
• English
• Hardback 978-0-12-809400-6

  9 7 8 - 0 - 1 2 - 8 0 9 4 0 0 - 6
• eBook 978-0-12-809445-7

  9 7 8 - 0 - 1 2 - 8 0 9 4 4 5 - 7

Adverse Events and Oncotargeted Kinase Inhibitors gathers and evaluates data on adverse events associated with tyrosine kinase inhibitors (TKIs), a powerful anti-tumor drug class that has recently been introduced for human therapy. This book compiles a comprehensive safety profile of each TKI from experiences in official therapeutic indications, also exploring off-label exploratory investigations and postmarketing pharmaceutical surveillance databases. A brief history of each drug’s development and submission is provided, along with a more detailed analysis of the mechanism(s) of action involved in therapeutic activity or related to the insurgence of specific adverse events. Early chapters focus on general characteristics of TKIs, typology, and classification of adverse events, while the final chapters analyze TKIs as AE inducers and classes of AEs by system or organ involvement. This comprehensive resource compiles and critically reviews all of the relevant safety data for this class of drugs, with the goal of improving the understanding of pathogenesis and facilitating the prevention, monitoring, and management of these adverse events.

Side Effects of Drugs Annual

• 1st Edition
• Volume 38
• October 25, 2016
• Sidhartha D. Ray
• English
• Hardback 978-0-444-63718-5

  9 7 8 - 0 - 4 4 4 - 6 3 7 1 8 - 5
• eBook 978-0-444-63889-2

  9 7 8 - 0 - 4 4 4 - 6 3 8 8 9 - 2

Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions was first published in 1977, and has been continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each annual provides clinicians and medical investigators with a reliable and critical survey of new data and trends in the area of adverse drug reactions and interactions, with an international team of specialists contributing their expertise each year.

Side Effects of Drugs Annual

• 1st Edition
• Volume 37
• November 4, 2015
• Sidhartha D. Ray
• English
• Hardback 978-0-444-63525-9

  9 7 8 - 0 - 4 4 4 - 6 3 5 2 5 - 9
• eBook 978-0-444-63531-0

  9 7 8 - 0 - 4 4 4 - 6 3 5 3 1 - 0

Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions was first published in 1977, and has been continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each Annual provides clinicians and medical investigators with a reliable and critical survey of new data and trends in the area of adverse drug reactions and interactions, with an international team of specialists contributing their expertise each year.